Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongyan Tong

Showing results (81-90 of 209) with videos related to

Pageof 21
Sort By:
British Journal of Haematology|May 25, 2023
Influenza A (H1N1) virus induced long-term remission in a refractory acute myeloid leukaemiaLiangshun You, Yi Liu, Nianci Chen, et al.
Journal of Cancer|April 15, 2021
Lower-dose decitabine improves clinical response compared with best supportive care in lower-risk MDS patients: a prospective, multicenter phase 2 studyLi Ye, Chen Mei, Yanling Ren, et al.
Frontiers in Oncology|June 26, 2023
Development and validation of platelet-to-albumin ratio as a clinical predictor for diffuse large B-cell lymphomaJinghan Wang, Linjie Li, Fang Yu, et al.
Leukemia Research|June 14, 2013
High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemiaQitian Mu, Yungui Wang, Bing Chen, et al.
Aging|April 23, 2021
High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemiaKongfei Li, Lieguang Chen, Hua Zhang, et al.
Zhonghua Yi Xue Za Zhi|January 28, 2016
[Bortezomib-induced peripheral neuropathy in multiple myeloma patients]Li Shao, Shasha Wang, Haitao Meng, et al.
Scientific Reports|November 9, 2017
Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulationChao Hu, Mengxia Yu, Yanling Ren, et al.
Hematology (Amsterdam, Netherlands)|November 28, 2024
First case of acute promyelocytic leukemia with TFG-RARA achieved complete remission treated with venetoclax and all-trans retinoic acidLi Zhu, Ting Shi, Yi Liu, et al.
Scientific Reports|June 8, 2017
PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulationChao Hu, Mengxia Yu, Yanling Ren, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 20, 2015
[Clinical and cytogenetic study of chromosome 1 abnormality in myelodysplastic syndrome]Wei Wang, Zhimei Chen, Mengxia Yu, et al.
Pageof 21

Showing results (81-90 of 209) with videos related to

Sort By:
Pageof 21
British Journal of Haematology|May 25, 2023
Influenza A (H1N1) virus induced long-term remission in a refractory acute myeloid leukaemiaLiangshun You, Yi Liu, Nianci Chen, et al.
Journal of Cancer|April 15, 2021
Lower-dose decitabine improves clinical response compared with best supportive care in lower-risk MDS patients: a prospective, multicenter phase 2 studyLi Ye, Chen Mei, Yanling Ren, et al.
Frontiers in Oncology|June 26, 2023
Development and validation of platelet-to-albumin ratio as a clinical predictor for diffuse large B-cell lymphomaJinghan Wang, Linjie Li, Fang Yu, et al.
Leukemia Research|June 14, 2013
High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemiaQitian Mu, Yungui Wang, Bing Chen, et al.
Aging|April 23, 2021
High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemiaKongfei Li, Lieguang Chen, Hua Zhang, et al.
Zhonghua Yi Xue Za Zhi|January 28, 2016
[Bortezomib-induced peripheral neuropathy in multiple myeloma patients]Li Shao, Shasha Wang, Haitao Meng, et al.
Scientific Reports|November 9, 2017
Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulationChao Hu, Mengxia Yu, Yanling Ren, et al.
Hematology (Amsterdam, Netherlands)|November 28, 2024
First case of acute promyelocytic leukemia with TFG-RARA achieved complete remission treated with venetoclax and all-trans retinoic acidLi Zhu, Ting Shi, Yi Liu, et al.
Scientific Reports|June 8, 2017
PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulationChao Hu, Mengxia Yu, Yanling Ren, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|October 20, 2015
[Clinical and cytogenetic study of chromosome 1 abnormality in myelodysplastic syndrome]Wei Wang, Zhimei Chen, Mengxia Yu, et al.
Pageof 21